mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.5 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
Nutlin-3 |
CCLE |
pan-cancer |
AAC |
0.03 |
0.5 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.5 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
Obatoclax Mesylate |
GDSC1000 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |